ConductScience.org, home

Paper41300282

Modeling Glioblastoma for Translation: Strengths and Pitfalls of Preclinical Studies.

D'Antonio C and 1 other. Biology (Basel), 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Modeling Glioblastoma for Translation: Strengths and Pitfalls of Preclinical Studies. Papers, record 41300282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41300282

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Modeling Glioblastoma for Translation: Strengths and Pitfalls of Preclinical Studies.
PubMed
Journal
Biology (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.44, provisional
iCite
Revised in PubMed
2025-11-30
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1D'Antonio CConcetta
2Liguori GLGiovanna Lhttps://orcid.org/0000-0002-7239-3224

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CEVITAEuropean Union-NextGenerationEUPubMed
University of Ljubljana VIP project NanostructuromePubMed

Source PubMed

Download CSV of grants

References180

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123333277Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ.Cell Rep2013https://conductscience.org/library/papers/23333277PubMed
222183788Calpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment.J Neurosci Res2012https://conductscience.org/library/papers/22183788PubMed
326629530The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes.EBioMedicine2015https://conductscience.org/library/papers/26629530PubMed
439799339Personalising glioblastoma medicine: explant organoid applications, challenges and future perspectives.Acta Neuropathol Commun2025https://conductscience.org/library/papers/39799339PubMed
511063134A quantitative model for differential motility of gliomas in grey and white matter.Cell Prolif2000https://conductscience.org/library/papers/11063134PubMed
633329756Universal scaling laws rule explosive growth in human cancers.Nat Phys2020https://conductscience.org/library/papers/33329756PubMed
729392690Establishing Primary Human Glioblastoma Tumorsphere Cultures from Operative Specimens.Methods Mol Biol2018https://conductscience.org/library/papers/29392690PubMed
87807177Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy.J Neurooncol1994https://conductscience.org/library/papers/7807177PubMed
927444372Computational models for predicting drug responses in cancer research.Brief Bioinform2017https://conductscience.org/library/papers/27444372PubMed
1039657679Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy.Cell Stem Cell2025https://conductscience.org/library/papers/39657679PubMed
1137400666Glioblastoma research on zebrafish xenograft models: a systematic review.Clin Transl Oncol2024https://conductscience.org/library/papers/37400666PubMed
1230191323Engineered 3D tumour model for study of glioblastoma aggressiveness and drug evaluation on a detachably assembled microfluidic device.Biomed Microdevices2018https://conductscience.org/library/papers/30191323PubMed
135475483Studies on the chemotherapy of experimental brain tumors: development of an experimental model.Cancer Res1970https://conductscience.org/library/papers/5475483PubMed
1418467254Intravenous administration of arsenic trioxide encapsulated in liposomes inhibits the growth of C6 gliomas in rat brains.J Chemother2008https://conductscience.org/library/papers/18467254PubMed
1526896279A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.Cancer Res2016https://conductscience.org/library/papers/26896279PubMed
1623630058Integration of microfluidic chip with biomimetic hydrogel for 3D controlling and monitoring of cell alignment and migration.J Biomed Mater Res A2014https://conductscience.org/library/papers/23630058PubMed
1723328810Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007.Neuro Oncol2013https://conductscience.org/library/papers/23328810PubMed
1831479239Tumor-Derived Extracellular Vesicles Breach the Intact Blood-Brain Barrier via Transcytosis.ACS Nano2019https://conductscience.org/library/papers/31479239PubMed
197435138Morphological characterization of nitrosourea-induced glioma cell lines and clones.Acta Neuropathol1980https://conductscience.org/library/papers/7435138PubMed
2034566587Comparison Between Human and Rodent Neurons for Persistent Activity Performance: A Biologically Plausible Computational Investigation.Front Syst Neurosci2021https://conductscience.org/library/papers/34566587PubMed

See all 180 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42794659Molecular Engineering of Aptamers for Glioblastoma Therapy: From Simple Antagonists to AI-Driven Approaches, a Narrative Review.Int J Mol Sci2026https://conductscience.org/library/papers/42794659PubMed
42474944Mitochondrial stress-induced cuproptosis: a metabolic bridge to reprogramming the GBM immune microenvironment.Cell Oncol (Dordr)2026https://conductscience.org/library/papers/42474944PubMed
42396877Mechanisms of Therapeutic Resistance and Recent Advances in Glioblastoma Treatment.Immunol Cell Biol2026https://conductscience.org/library/papers/42396877PubMed
42347034Optimized Wound Healing Assay to Study Extracellular Vesicle-Driven Glioblastoma Cell Migration.Methods Protoc2026https://conductscience.org/library/papers/42347034PubMed
42252325Overexpression of miR-219 as a potential therapeutic strategy of glioblastoma cells in vitro.Sci Rep2026https://conductscience.org/library/papers/42252325PubMed
42017986Interactions and communications in the glioblastoma microenvironment: potential targets for chemo-/radiotherapy.Strahlenther Onkol2026https://conductscience.org/library/papers/42017986PubMed
41836519Closing the loop on glioblastoma: A roadmap toward developing bioelectronics for continuous monitoring of tumor state.APL Bioeng2026https://conductscience.org/library/papers/41836519PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41300282

GET https://conductscience.org/api/papers/v1/41300282/references?page=2